Merilog is expected to be available in July 2025, and Sanofi will provide Merilog to patients for $35 or less for a 30-day ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

NovoLog FlexPen, NovoLog PenFill are all insulin or insulin infectors for patients with diabetes. Last year, they ran a list price of $495 for 30 days, the new price of $119 is 76% cheaper.

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

your insulin costs will be $35 a month, period," he said. The agreement reached with Novo Nordisk covers popular brands like Flasp, Novolin, NovoLog and Tresib, with three vials or two packs of ...

Products like novolog, novomix, and novorapid are contributing significantly to diabetes management by providing rapid-acting insulin for quick blood sugar reduction and, in the case of novomix ...

A chronic medical condition, diabetes results in the body's inability to produce enough insulin or use it effectively, leading to high blood sugar levels. Interestingly, Novolog Mix 70 or 30 ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

Like its reference counterpart, insulin aspart (Novolog), the biosimilar helps lower mealtime blood sugar spikes to improve glycemic control. The approval is for both a 3 mL single-patient-use ...

SILVER SPRING, Md., Feb. 14, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement ...